Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Minerva Neurosciences, Inc (NERV) had Return on Equity of -5.60% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$1.44M |
|
-- |
|
-- |
|
$21.85M |
|
$-21.85M |
|
$23.29M |
|
$1.44M |
|
$1.44M |
|
$1.44M |
|
$1.44M |
|
$1.44M |
|
$1.44M |
|
$-21.85M |
|
$-21.83M |
|
7.57M |
|
7.57M |
|
$0.19 |
|
$0.19 |
|
| Balance Sheet Financials | |
$22.27M |
|
$0.01M |
|
$14.87M |
|
$37.14M |
|
$2.84M |
|
-- |
|
$60.00M |
|
$62.84M |
|
$-25.69M |
|
$-40.56M |
|
$-25.69M |
|
6.99M |
|
| Cash Flow Statement Financials | |
$-19.55M |
|
-- |
|
-- |
|
$41.01M |
|
$21.46M |
|
$-19.55M |
|
$1.33M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.85 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-19.55M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-5.60% |
-3.55% |
|
3.87% |
|
-5.60% |
|
$-3.67 |
|
$-2.58 |
|
$-2.58 |
|